Related references
Note: Only part of the references are listed.Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel
Anne M. Noonan et al.
CLINICAL CANCER RESEARCH (2013)
Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)
L. R. Molife et al.
ANNALS OF ONCOLOGY (2010)
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
Virginia M. Klimek et al.
CLINICAL CANCER RESEARCH (2008)
HDAC inhibitors and cardiac safety
Rhoda Molife et al.
CLINICAL CANCER RESEARCH (2007)
Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors
Manisha H. Shah et al.
CLINICAL CANCER RESEARCH (2006)
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphoma
Richard L. Piekarz et al.
CLINICAL CANCER RESEARCH (2006)
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding
HJ Kee et al.
CIRCULATION (2006)
Concurrent opposite effects of trichostatin A, an inhibitor of histone deacetylases, on expression of α-MHC and cardiac tubulins:: implication for gain in cardiac muscle contractility
FJ Davis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia
JC Byrd et al.
BLOOD (2005)
Effect of a histone deacetylase inhibitor on human cardiac mass
Y Shizukuda et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes
RR Alcendor et al.
CIRCULATION RESEARCH (2004)
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors
CL Antos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
Share Paper
